Showing 7791-7800 of 20409 results for "".
Post-Hoc Analysis of Scalp Psoriasis Treatment After Five Years
https://reachmd.com/programs/clinicians-roundtable/post-hoc-analysis-of-scalp-psoriasis-treatment-after-five-years/24371/Scalp psoriasis can be a particularly challenging manifestation for many patients. Tune in to learn more.Unveiling the Link Between Dermatological and Cardiovascular Health
https://reachmd.com/programs/clinicians-roundtable/unveiling-the-link-between-dermatological-and-cardiovascular-health/32381/Explore the link between dermatological conditions and cardiovascular health, and discover new diagnostic and treatment possibilities.Detecting Multiple Sclerosis Earlier: PRLs and the Evolving McDonald Diagnostic Criteria
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/detecting-multiple-sclerosis-earlier-prls-and-the-evolving-mcdonald-diagnostic-criteria/54390/This episode explores new evidence showing that paramagnetic rim lesions (PRLs) are highly prevalent early in multiple sclerosis (MS) and can differentiate MS from mimics with striking accuracy. Daniel Ontaneda, MD, PhD, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, and Pascal Sati, PhDiagnosing Rett Syndrome: A Lifespan Approach to Clinical Recognition
https://reachmd.com/programs/cme/diagnosing-rett-syndrome-a-lifespan-approach-to-clinical-recognition/57129/Explore diagnosis, multidisciplinary management, and long-term care strategies for patients with Rett syndrome across the lifespan.Clinical Pearls in Recognizing Rett Syndrome: Early Signs and Diagnosis
https://reachmd.com/programs/cme/clinical-pearls-in-recognizing-rett-syndrome-early-signs-and-diagnosis/57130/Explore diagnosis, multidisciplinary management, and long-term care strategies for patients with Rett syndrome across the lifespan.Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
https://reachmd.com/programs/project-oncology/cgvhd-second-third-line-treatment-decisions/54338/Currently, there’s no standard approach for sequencing therapies in chronic graft-versus-host disease (cGVHD) once patients progress beyond first-line treatment. Given this gap, Dr. Charles Turck speaks with Ms. Stephanie Gregory about how we can optimize our treatment decisions in the second- and tRecognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
https://reachmd.com/programs/neurofrontiers/recognizing-ms-understanding-symptoms-and-avoiding-misdiagnosis/36361/Early symptoms of multiple sclerosis (MS) often present as clear, localized neurological changes lasting several days. However, many nonspecific complaints and common MRI findings can mimic MS, leading to misdiagnosis and unnecessary treatment. Dr. Jonathan Howard, an Associate Professor of NeurologHow DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
https://reachmd.com/programs/neurofrontiers/how-ddl-920-could-help-restore-cognitive-function-in-alzheimers-patients/18073/GOLD Guidelines for COPD Care: Evolving Strategies for Exacerbation Prevention
https://reachmd.com/programs/clinicians-roundtable/gold-guidelines-for-copd-care-evolving-strategies-for-exacerbation-prevention/26399/Tune in to discover the recent changes to the GOLD guidelines for COPD management.Emerging Bronchoscopic Treatments for COPD: A Review of Clinical Trials
https://reachmd.com/programs/clinicians-roundtable/emerging-bronchoscopic-treatments-for-copd-a-review-of-clinical-trials/26395/There are several bronchoscopic treatments for chronic obstructive pulmonary disease in the clinical trial phase. Here’s a review of the research.